Literature DB >> 10968947

Comparison of pathogenic properties between two types of arginine-specific cysteine proteinases (gingipains-R) from Porphyromonas gingivalis.

T Imamura1, J Potempa, J Travis.   

Abstract

Two major arginine-specific cysteine proteinases (gingipains R) from Porphyromonas gingivalis have been compared with regard to their potential participation in the pathology of periodontal disease. Both the high and low molecular mass forms, HRgpA and RgpB, cleaved oligopeptide fluorogenic substrates at the P1-arginine residue with essentially identical specificity but different efficiencies, with HRgpA being about 1.5 to seven-fold less potent than RgpB. In contrast HRgpA, which occurs as a non-covalent complex of catalytic and hemagglutinin/adhesion domains, was about two-fold more active than RgpB in degrading fibrinogen and fibrin, while both enzymes activated prekallikrein with similar efficiency. These data indicate the likelihood that both activities could be involved in both the bleeding tendency and production of gingival crevicular fluid, which occur at infected periodontitis sites. Significantly, however, is the fact that HRgpA, but not RgpB, was able to bind phospholipids in the presence of calcium ions, the effect dramatically enhancing the activation of clotting factors by this proteinase. This suggests that HRgpA may play a more important role in the virulence of Porphyromonas gingivalis, relative to RgpB, almost certainly because of the presence of the hemagglutinin/adhesion domain which can bind phospholipid and apparently modulate enzyme activity. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968947     DOI: 10.1006/mpat.2000.0380

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  5 in total

1.  Activation of blood coagulation factor IX by gingipains R, arginine-specific cysteine proteinases from Porphyromonas gingivalis.

Authors:  T Imamura; S Tanase; T Hamamoto; J Potempa; J Travis
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

2.  Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues.

Authors:  T Imamura; K Matsushita; J Travis; J Potempa
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

3.  Proteolysis of CD14 on human gingival fibroblasts by arginine-specific cysteine proteinases from Porphyromonas gingivalis leading to down-regulation of lipopolysaccharide-induced interleukin-8 production.

Authors:  Hiroyuki Tada; Shunji Sugawara; Eiji Nemoto; Nobuhiro Takahashi; Takahisa Imamura; Jan Potempa; James Travis; Hidetoshi Shimauchi; Haruhiko Takada
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Parkinson's Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens.

Authors:  Büin Adams; J Massimo Nunes; Martin J Page; Timothy Roberts; Jonathan Carr; Theo A Nell; Douglas B Kell; Etheresia Pretorius
Journal:  Front Aging Neurosci       Date:  2019-08-27       Impact factor: 5.750

5.  Proteolysis of Gingival Keratinocyte Cell Surface Proteins by Gingipains Secreted From Porphyromonas gingivalis - Proteomic Insights Into Mechanisms Behind Tissue Damage in the Diseased Gingiva.

Authors:  Katarina Hočevar; Matej Vizovišek; Alicia Wong; Joanna Kozieł; Marko Fonović; Barbara Potempa; Richard J Lamont; Jan Potempa; Boris Turk
Journal:  Front Microbiol       Date:  2020-04-28       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.